News - ImmunoScape

ImmunoScape To Present at the 7th Annual CAR-TCR Summit

Sep 14, 2022

ImmunoScape To Present at the 7th Annual CAR-TCR Summit San Diego, California and Singapore – September 14, 2022 – ImmunoScape, a pre-clinical...

ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors

Sep 14, 2022

ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors Anzu Partners led the $14M...

Read our latest publication together with NAIAD and Johns Hopkins University on the T cell response to the mutations found in the omicron variant of SARS-CoV-2

Mar 21, 2022

ImmunoScape has continued its COVID-19 collaboration with NIAID and the Johns Hopkins University. Read our paper here: Minimal Crossover between...

ImmunoScape Inks Licensing Deal with Pure MHC to Advance Development of Novel TCR- Based Therapies

Feb 16, 2022

SINGAPORE, SAN DIEGO, OKLAHOMA CITY, and AUSTIN – February 16, 2022 – ImmunoScape, a pre-clinical biotechnology company focused on the discovery and...

ImmunoScape Expands its Executive and Scientific Teams to Extend Use of its Deep Immunomics Platform into Drug Discovery

Jun 29, 2021

SINGAPORE and SAN DIEGO – June 29, 2021 – ImmunoScape, a biotech company with an immunomics-based technology platform that provides novel insights...

ImmunoScape Raises $14M To Advance Deep Immunomics Platform for High-Dimensional Immune Profiling and Drug Discovery

Apr 14, 2021

SINGAPORE and SAN DIEGO – April 14, 2021 – ImmunoScape, a biotech company with an immunomics-based technology platform that provides novel insights...